{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:20:02Z","timestamp":1779200402366,"version":"3.51.4"},"publisher-location":"Cham","reference-count":83,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030504939","type":"print"},{"value":"9783030504946","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/164_2019_337","type":"book-chapter","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T10:02:58Z","timestamp":1578909778000},"page":"67-86","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["GH and IGF-1 Replacement in Children"],"prefix":"10.1007","author":[{"given":"Roland","family":"Pf\u00e4ffle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wieland","family":"Kiess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"337_CR1","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1210\/jc.2008-0707","volume":"93","author":"K Albertsson-Wikland","year":"2008","unstructured":"Albertsson-Wikland K, Aronson SA, Gustafsson J, Hagen\u00e4s L, Ivarsson SA, Jonsson B et al (2008) Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency. J Clin Endocrinol Metabol 93:4342\u20134350","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR2","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1210\/jc.2015-3951","volume":"101","author":"K Albertsson-Wikland","year":"2016","unstructured":"Albertsson-Wikland K, M\u00e5rtensson A, S\u00e4vendahl L, Niklasson A, Bang P, Dahlgren J et al (2016) Mortality is not increased in recombinant human growth hormone-treated patients when adjusting for birth characteristics. J Clin Endocrinol Metabol 101:2149\u20132159","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR3","first-page":"1504","volume":"86","author":"PF Backeljauw","year":"2001","unstructured":"Backeljauw PF, Underwood LE (2001) Therapy for 6.5\u20137.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: a clinical research center study 1. J Clin Endocrinol Metabol 86:1504\u20131510","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/cen.12848","volume":"83","author":"A Berglund","year":"2015","unstructured":"Berglund A, Gravholt C, Olsen M, Christiansen J, Stochholm K (2015) Growth hormone replacement does not increase mortality in patients with childhood-onset growth hormone deficiency. Clin Endocrinol (Oxf) 83:677\u2013683","journal-title":"Clin Endocrinol (Oxf)"},{"key":"337_CR5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000243781","volume":"72","author":"G Binder","year":"2009","unstructured":"Binder G (2009) Response to growth hormone in short children with Noonan syndrome: correlation to genotype. Horm Res Paediatr 72:52\u201356","journal-title":"Horm Res Paediatr"},{"key":"337_CR6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000023131","volume":"49","author":"R Birnbacher","year":"1998","unstructured":"Birnbacher R, Riedl S, Frisch H (1998) Long-term treatment in children with hypopituitarism: pubertal development and final height. Horm Res Paediatr 49:80\u201385","journal-title":"Horm Res Paediatr"},{"key":"337_CR7","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/jcem.82.2.3734","volume":"82","author":"S Blethen","year":"1997","unstructured":"Blethen S (1997) Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. J Clin Endocrinol Metabol 82:418\u2013420","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR8","first-page":"574","volume":"76","author":"S Blethen","year":"1993","unstructured":"Blethen S, Compton P, Lippe B, Rosenfeld R, August G, Johanson A (1993) Factors predicting the response to growth hormone (GH) therapy in prepubertal children with GH deficiency. J Clin Endocrinol Metabol 76:574\u2013579","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/jc.2006-1409","volume":"92","author":"WF Blum","year":"2007","unstructured":"Blum WF, Crowe BJ, Quigley CA, Jung H, Cao D, Ross JL et al (2007) Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: two-year results of a randomized, controlled, multicenter trial. J Clin Endocrinol Metabol 92:219\u2013228","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR10","doi-asserted-by":"crossref","first-page":"E1383","DOI":"10.1210\/jc.2013-1222","volume":"98","author":"WF Blum","year":"2013","unstructured":"Blum WF, Ross JL, Zimmermann AG, Quigley CA, Child CJ, Kalifa G et al (2013) GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial. J Clin Endocrinol Metabol 98:E1383\u2013E1392","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1210\/jc.2007-1723","volume":"93","author":"K Bolar","year":"2008","unstructured":"Bolar K, Hoffman AR, Maneatis T, Lippe B (2008) Long-term safety of recombinant human growth hormone in turner syndrome. J Clin Endocrinol Metabol 93:344\u2013351","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR12","doi-asserted-by":"crossref","unstructured":"Bryant J, Baxter L, Cave CB, Milne R (2007) Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Db Syst Rev:CD004440","DOI":"10.1002\/14651858.CD004440.pub2"},{"key":"337_CR13","first-page":"1462","volume":"83","author":"J-C Carel","year":"1998","unstructured":"Carel J-C, Mathivon L, Gendrel C, Ducret J-P, Chaussain J-L (1998) Near normalization of final height with adapted doses of growth hormone in Turner\u2019s syndrome. J Clin Endocrinol Metabol 83:1462\u20131466","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR83","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1210\/jc.2002-021123","volume":"88","author":"J-C Carel","year":"2003","unstructured":"Carel J-C, Chatelain P, Rochiccioli P, Chaussain J-L (2003) Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: results of a randomized controlled study. J Clin Endocrinol Metab 88:1587\u20131593. https:\/\/doi.org\/10.1210\/jc.2002-021123","journal-title":"J Clin Endocrinol Metab"},{"key":"337_CR14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1210\/jc.2011-1995","volume":"97","author":"J-C Carel","year":"2012","unstructured":"Carel J-C, Ecosse E, Landier F et al (2012) Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study. J Clin Endocrinol Metab 97:416\u2013425. https:\/\/doi.org\/10.1210\/jc.2011-1995","journal-title":"J Clin Endocrinol Metab"},{"key":"337_CR15","doi-asserted-by":"publisher","unstructured":"Cave CB, Bryant J, Milne R (2003) Recombinant growth hormone in children and adolescents with Turner syndrome. Cochrane Database Syst Rev 2003(1). Art. No.: CD003887. https:\/\/doi.org\/10.1002\/14651858.CD003887 . www.cochranelibrary.com","DOI":"10.1002\/14651858.CD003887"},{"key":"337_CR16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.279.5350.563","volume":"279","author":"JM Chan","year":"1998","unstructured":"Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P et al (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279:563\u2013566","journal-title":"Science"},{"key":"337_CR17","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1210\/jc.2016-3776","volume":"102","author":"P Chatelain","year":"2017","unstructured":"Chatelain P, Malievsky O, Radziuk K, Senatorova G, Abdou MO, Vlachopapadopolou E et al (2017) A randomized phase 2 study of long-acting TransCon GH vs daily GH in childhood GH deficiency. J Clin Endocrinol Metabol 102:1673\u20131682","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR18","first-page":"2439","volume":"85","author":"SD Chernausek","year":"2000","unstructured":"Chernausek SD, Attie KM, Cara JF, Rosenfeld RG, Frane J (2000) Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height 1. J Clin Endocrinol Metabol 85:2439\u20132445","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR19","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1210\/jc.2006-1610","volume":"92","author":"SD Chernausek","year":"2007","unstructured":"Chernausek SD, Backeljauw PF, Frane J, Kuntze J, Underwood LE, Group IG (2007) Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. J Clin Endocrinol Metabol 92:902\u2013910","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR20","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1530\/EJE-16-0111","volume":"174","author":"J Christiansen","year":"2016","unstructured":"Christiansen J, Backeljauw PF, Bidlingmaier M, Biller BM, Boguszewski MC, Casanueva FF et al (2016) Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations. Eur J Endocrinol 174:C1\u2013C8","journal-title":"Eur J Endocrinol"},{"key":"337_CR21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1210\/jc.2006-2017","volume":"92","author":"P Clayton","year":"2007","unstructured":"Clayton P, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A (2007) Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metabol 92:804\u2013810","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR22","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1210\/jc.2007-0204","volume":"92","author":"P Cohen","year":"2007","unstructured":"Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard A-M, Rosenfeld RG et al (2007) Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J Clin Endocrinol Metabol 92:2480\u20132486","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR23","doi-asserted-by":"crossref","first-page":"e16223","DOI":"10.1371\/journal.pone.0016223","volume":"6","author":"WS Cutfield","year":"2011","unstructured":"Cutfield WS, Derraik JG, Gunn AJ, Reid K, Delany T, Robinson E et al (2011) Non-compliance with growth hormone treatment in children is common and impairs linear growth. Plos One 6:e16223","journal-title":"Plos One"},{"key":"337_CR24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1203\/01.PDR.0000148716.71231.81","volume":"57","author":"J Dahlgren","year":"2005","unstructured":"Dahlgren J, Wikland K, Swedish Study Group for Growth Hormone Treatment (2005) Final height in short children born small for gestational age treated with growth hormone. Pediatr Res 57:216\u2013222","journal-title":"Pediatr Res"},{"key":"337_CR25","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1210\/jc.2006-2874","volume":"92","author":"ML Davenport","year":"2007","unstructured":"Davenport ML, Crowe BJ, Travers SH, Rubin K, Ross JL, Fechner PY et al (2007) Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial. J Clin Endocrinol Metabol 92:3406\u20133416","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR26","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.1542\/peds.2004-1934","volume":"115","author":"F de Zegher","year":"2005","unstructured":"de Zegher F, Hokken-Koelega A (2005) Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term. Pediatrics 115:e458\u2013e462","journal-title":"Pediatrics"},{"key":"337_CR27","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nbt.2438","volume":"30","author":"HC Ebbers","year":"2012","unstructured":"Ebbers HC, Crow SA, Vulto AG, Schellekens H (2012) Interchangeability, immunogenicity and biosimilars. Nat Biotechnol 30:1186","journal-title":"Nat Biotechnol"},{"key":"337_CR28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000082745","volume":"63","author":"U Eiholzer","year":"2005","unstructured":"Eiholzer U (2005) Deaths in children with Prader-Willi syndrome. Horm Res Paediatr 63:33\u201339","journal-title":"Horm Res Paediatr"},{"key":"337_CR29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000139150","volume":"70","author":"CJ Elder","year":"2008","unstructured":"Elder CJ, Barton JS, Brook CGD, Preece MA, Dattani MT, Hindmarsh PC (2008) A randomised study of the effect of two doses of biosynthetic human growth hormone on final height of children with familial short stature. Horm Res Paediatr 70:89\u201392","journal-title":"Horm Res Paediatr"},{"key":"337_CR30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2265.2008.03228.x","volume":"69","author":"DA Festen","year":"2008","unstructured":"Festen DA, van Wijngaarden R, Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ et al (2008) Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader\u2013Willi syndrome. Clin Endocrinol (Oxf) 69:443\u2013451","journal-title":"Clin Endocrinol (Oxf)"},{"key":"337_CR31","first-page":"3323","volume":"81","author":"E Ghigo","year":"1996","unstructured":"Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M et al (1996) Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metabol 81:3323\u20133327","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR32","doi-asserted-by":"crossref","first-page":"281544a0","DOI":"10.1038\/281544a0","volume":"281","author":"DV Goeddel","year":"1979","unstructured":"Goeddel DV, Heyneker HL, Hozumi T, Arentzen R, Itakura K, Yansura DG et al (1979) Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone. Nature 281:281544a0","journal-title":"Nature"},{"key":"337_CR33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1515\/JPEM.2001.14.4.377","volume":"14","author":"Growth Hormone Research Society","year":"2001","unstructured":"Growth Hormone Research Society (2001) Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Pediatr Endocrinol Metabol 14:377\u2013382","journal-title":"J Pediatr Endocrinol Metabol"},{"key":"337_CR34","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","volume":"351","author":"SE Hankinson","year":"1998","unstructured":"Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B et al (1998) Circulating concentrations of insulin-like growth factor I and risk of breast cancer. Lancet 351:1393\u20131396","journal-title":"Lancet"},{"key":"337_CR35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM199902183400702","volume":"340","author":"RL Hintz","year":"1999","unstructured":"Hintz RL, Attie KM, Baptista J, Roche A (1999) Effect of growth hormone treatment on adult height of children with idiopathic short stature. N Engl J Med 340:502\u2013507","journal-title":"N Engl J Med"},{"key":"337_CR36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ghir.2015.07.004","volume":"25","author":"C H\u00f8ybye","year":"2015","unstructured":"H\u00f8ybye C, Cohen P, Hoffman AR, Ross R, Biller B, Christiansen J et al (2015) Status of long-acting-growth hormone preparations \u2013 2015. Growth Horm IGF Res 25:201\u2013206","journal-title":"Growth Horm IGF Res"},{"key":"337_CR37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/EJE-13-0148","volume":"169","author":"J Hwang","year":"2013","unstructured":"Hwang J, Lee H, Chung W, Han H-S, Jin D-K, Kim H-S et al (2013) Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency. Eur J Endocrinol 169:179\u2013185","journal-title":"Eur J Endocrinol"},{"key":"337_CR38","doi-asserted-by":"crossref","first-page":"pr1983158","DOI":"10.1203\/00006450-198308000-00015","volume":"17","author":"E Joss","year":"1983","unstructured":"Joss E, Zuppinger K, Schwarz H, Roten H (1983) Final height of patients with pituitary growth failure and changes in growth variables after long term hormonal therapy. Pediatr Res 17:pr1983158","journal-title":"Pediatr Res"},{"key":"337_CR39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.beem.2010.09.012","volume":"25","author":"J Klammt","year":"2011","unstructured":"Klammt J, Kiess W, Pf\u00e4ffle R (2011) IGF1R mutations as cause of SGA. Best Pract Res Clin Endocrinol Metabol 25:191\u2013206","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"337_CR40","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1542\/peds.111.6.1253","volume":"111","author":"PA Lee","year":"2003","unstructured":"Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P, International Small for Gestational Age Advisory Board (2003) International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24\u2013October 1, 2001. Pediatrics 111:1253\u20131261","journal-title":"Pediatrics"},{"key":"337_CR41","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1210\/jc.2003-031457","volume":"89","author":"E Leschek","year":"2004","unstructured":"Leschek E, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ et al (2004) Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metabol 89:3140\u20133148","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00024677-200605040-00003","volume":"5","author":"AC Lindgren","year":"2006","unstructured":"Lindgren AC (2006) Somatropin therapy for children with Prader-Willi syndrome. Treat Endocrinol 5:223\u2013228","journal-title":"Treat Endocrinol"},{"key":"337_CR43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000145019","volume":"70","author":"AC Lindgren","year":"2008","unstructured":"Lindgren AC, Lindberg A (2008) Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database). Horm Res Paediatr 70:182\u2013187","journal-title":"Horm Res Paediatr"},{"key":"337_CR44","first-page":"1167","volume":"85","author":"DF Luca","year":"1996","unstructured":"Luca DF, Maghnie M, Arrigo T, Lombardo F, Messina M, Bernasconi S (1996) Final height outcome of growth hormone-deficient patients treated since less than five years of age. Acta Paediatr 85:1167\u20131171","journal-title":"Acta Paediatr"},{"key":"337_CR45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EJE-16-0905","volume":"177","author":"X Luo","year":"2017","unstructured":"Luo X, Hou L, Liang L, Dong G, Shen S, Zhao Z et al (2017) Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies. Eur J Endocrinol 177:195\u2013205","journal-title":"Eur J Endocrinol"},{"key":"337_CR46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1542\/peds.102.S3.527","volume":"102","author":"M MacGillivray","year":"1998","unstructured":"MacGillivray M, Blethen S, Buchlis J, Clopper R, Sandberg D, Conboy T (1998) Current dosing of growth hormone in children with growth hormone deficiency: how physiologic? Pediatrics 102:527\u2013530","journal-title":"Pediatrics"},{"key":"337_CR47","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1210\/jc.2006-0050","volume":"91","author":"M Maghnie","year":"2006","unstructured":"Maghnie M, Ambrosini L, Cappa M, Pozzobon G, Ghizzoni L, Ubertini M et al (2006) Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies. J Clin Endocrinol Metabol 91:2900\u20132905","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1067\/mpd.2000.105369","volume":"137","author":"SE Myers","year":"2000","unstructured":"Myers SE, Carrel AL, Whitman BY, Allen DB (2000) Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. J Pediatr 137:42\u201349","journal-title":"J Pediatr"},{"key":"337_CR49","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1210\/jc.2009-0452","volume":"94","author":"I Netchine","year":"2009","unstructured":"Netchine I, Azzi S, Houang M, Seurin D, Perin L, Ricort J-M et al (2009) Partial primary deficiency of insulin-like growth factor (IGF)-I activity associated with IGF1 mutation demonstrates its critical role in growth and brain development. J Clin Endocrinol Metabol 94:3913\u20133921","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR50","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ajmg.1320460106","volume":"46","author":"RD Nicholls","year":"1993","unstructured":"Nicholls RD (1993) Genomic imprinting and uniparental disomy in Angelman and Prader-Willi syndromes: a review. Am J Med Genet 46:16\u201325","journal-title":"Am J Med Genet"},{"key":"337_CR51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/EJE-08-0413","volume":"159","author":"C Noordam","year":"2008","unstructured":"Noordam C, Peer P, Francois I, Schepper DJ, van den Burgt I, Otten B (2008) Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11. Eur J Endocrinol 159:203\u2013208","journal-title":"Eur J Endocrinol"},{"key":"337_CR52","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1651-2227.2005.tb02081.x","volume":"94","author":"D Osio","year":"2005","unstructured":"Osio D, Dahlgren J, Wikland K, Westphal O (2005) Improved final height with long-term growth hormone treatment in Noonan syndrome. Acta Paediatr 94:1232\u20131237","journal-title":"Acta Paediatr"},{"key":"337_CR53","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1210\/jc.2002-021172","volume":"88","author":"Y Pareren","year":"2003","unstructured":"Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A (2003) Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial. J Clin Endocrinol Metabol 88:3584\u20133590","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR54","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/BF03347202","volume":"28","author":"A Pasquino","year":"2005","unstructured":"Pasquino A, Pucarelli I, Segni M, Tarani L, Calcaterra V, Larizza D (2005) Adult height in sixty girls with Turner syndrome treated with growth hormone matched with an untreated group. J Endocrinol Invest 28:350\u2013356","journal-title":"J Endocrinol Invest"},{"key":"337_CR55","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1212\/WNL.0000000000000737","volume":"83","author":"A Poidvin","year":"2014","unstructured":"Poidvin A, Touz\u00e9 E, Ecosse E, Landier F, B\u00e9jot Y, Giroud M et al (2014) Growth hormone treatment for childhood short stature and risk of stroke in early adulthood. Neurology 83:780\u2013786","journal-title":"Neurology"},{"key":"337_CR56","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1210\/jcem.87.5.8477","volume":"87","author":"CA Quigley","year":"2002","unstructured":"Quigley CA, Crowe BJ, Anglin GD, Chipman JJ (2002) Growth hormone and low dose estrogen in turner syndrome: results of a united states multi-center trial to near-final height. J Clin Endocrinol Metabol 87:2033\u20132041","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1515\/JPEM.2008.21.3.267","volume":"21","author":"R Raaijmakers","year":"2008","unstructured":"Raaijmakers R, Noordam C, Karagiannis G, Gregory JW, Hertel NT, Sipil\u00e4 I et al (2008) Response to growth hormone treatment and final height in Noonan syndrome in a large cohort of patients in the KIGS database. J Pediatr Endocrinol Metabol 21:267\u2013274","journal-title":"J Pediatr Endocrinol Metabol"},{"key":"337_CR58","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1126\/science.125.3253.883","volume":"125","author":"M Raben","year":"1957","unstructured":"Raben M (1957) Preparation of growth hormone from pituitaries of man and monkey. Science 125:883\u2013884","journal-title":"Science"},{"key":"337_CR59","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000380851","volume":"83","author":"MB Ranke","year":"2015","unstructured":"Ranke MB (2015) Treatment with recombinant human insulin-like growth factor-1 in severe primary IGF deficiency and beyond. Horm Res Paediatr 83:358\u2013360","journal-title":"Horm Res Paediatr"},{"key":"337_CR60","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrendo.2018.22","volume":"14","author":"MB Ranke","year":"2018","unstructured":"Ranke MB, Wit JM (2018) Growth hormone \u2013 past, present and future. Nat Rev Endocrinol 14:285","journal-title":"Nat Rev Endocrinol"},{"key":"337_CR61","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1530\/eje.0.1470625","volume":"147","author":"PC Ranke","year":"2002","unstructured":"Ranke PC, Lindberg A, Dorr H, Bettendorf M, Hauffa B et al (2002) Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001. Eur J Endocrinol 147:625\u2013633","journal-title":"Eur J Endocrinol"},{"key":"337_CR62","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1210\/jc.2009-1471","volume":"95","author":"MB Ranke","year":"2010","unstructured":"Ranke MB, Lindberg A, Board K (2010) Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables. J Clin Endocrinol Metabol 95:1229\u20131237","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR63","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ng0597-54","volume":"16","author":"E Rao","year":"1997","unstructured":"Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A et al (1997) Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 16:54\u201363","journal-title":"Nat Genet"},{"key":"337_CR64","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/jmg.2006.046581","volume":"44","author":"G Rappold","year":"2007","unstructured":"Rappold G, Blum WF, Shavrikova EP, Crowe BJ, Roeth R, Quigley CA et al (2007) Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency. J Med Genet 44:306","journal-title":"J Med Genet"},{"key":"337_CR65","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s12325-008-0124-9","volume":"25","author":"EJ Richmond","year":"2008","unstructured":"Richmond EJ, Rogol AD (2008) Recombinant human insulin-like growth factor-I therapy for children with growth disorders. Adv Ther 25:1276","journal-title":"Adv Ther"},{"key":"337_CR66","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000316130","volume":"18","author":"E Richmond","year":"2010","unstructured":"Richmond E, Rogol AD (2010) Current indications for growth hormone therapy for children and adolescents. Endocr Dev 18:92\u2013108","journal-title":"Endocr Dev"},{"key":"337_CR67","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1210\/jc.2008-2094","volume":"94","author":"AA Romano","year":"2009","unstructured":"Romano AA, Dana K, Bakker B, Davis AD, Hunold J, Jacobs J et al (2009) Growth response, near-adult height, and patterns of growth and puberty in patients with Noonan syndrome treated with growth hormone. J Clin Endocrinol Metabol 94:2338\u20132344","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR68","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0022-3476(98)70452-4","volume":"132","author":"RG Rosenfeld","year":"1998","unstructured":"Rosenfeld RG, Attie KM, Frane J, Brasel A, Burstein S, Cara JF et al (1998) Growth hormone therapy of Turner\u2019s syndrome: beneficial effect on adult height. J Pediatr 132:319\u2013324","journal-title":"J Pediatr"},{"key":"337_CR69","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/14767058.2013.832870","volume":"26","author":"G Saggese","year":"2013","unstructured":"Saggese G, Fanos M, Simi F (2013) SGA children: auxological and metabolic outcomes \u2013 the role of GH treatment. J Matern Fetal Neonatal Med 26:64\u201367","journal-title":"J Matern Fetal Neonatal Med"},{"key":"337_CR70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/er.2006-0001","volume":"28","author":"A Samani","year":"2007","unstructured":"Samani A, Yakar S, LeRoith D, Brodt P (2007) The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28:20\u201347","journal-title":"Endocr Rev"},{"key":"337_CR71","doi-asserted-by":"crossref","first-page":"E213","DOI":"10.1210\/jc.2011-2882","volume":"97","author":"L S\u00e4vendahl","year":"2012","unstructured":"S\u00e4vendahl L, Maes M, Albertsson-Wikland K, Borgstr\u00f6m B, Carel J-C, Henrard S et al (2012) Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study. J Clin Endocrinol Metabol 97:E213\u2013E217","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR72","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1210\/jc.2005-0470","volume":"90","author":"L Soriano-Guillen","year":"2005","unstructured":"Soriano-Guillen L, Coste J, Ecosse E, L\u00e9ger J, Tauber M, Cabrol S et al (2005) Adult height and pubertal growth in turner syndrome after treatment with recombinant growth hormone. J Clin Endocrinol Metabol 90:5197\u20135204","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR73","doi-asserted-by":"crossref","first-page":"R171","DOI":"10.1530\/EC-17-0203","volume":"6","author":"K Sprog\u00f8e","year":"2017","unstructured":"Sprog\u00f8e K, Mortensen E, Karpf DB, Leff JA (2017) The rationale and design of TransCon growth hormone for the treatment of growth hormone deficiency. Endocr Connect 6:R171\u2013R181","journal-title":"Endocr Connect"},{"key":"337_CR74","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1210\/jc.2004-2187","volume":"90","author":"DK Stephure","year":"2005","unstructured":"Stephure DK, Committee C (2005) Impact of growth hormone supplementation on adult height in Turner syndrome: results of the canadian randomized controlled trial. J Clin Endocrinol Metabol 90:3360\u20133366","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR75","first-page":"1","volume":"14","author":"A Takeda","year":"2010","unstructured":"Takeda A, Cooper K, Bird A, Baxter L, Frampton G, Gospodarevskaya E et al (2010) Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation. Health Technol Assess (Winch Eng) 14:1\u2013209. iii\u2013iv","journal-title":"Health Technol Assess (Winch Eng)"},{"key":"337_CR76","first-page":"531","volume":"82","author":"V Tillmann","year":"1997","unstructured":"Tillmann V, Buckler JM, Kibirige MS, Price DA, Shalet SM, Wales JK et al (1997) Biochemical tests in the diagnosis of childhood growth hormone deficiency 1. J Clin Endocrinol Metabol 82:531\u2013535","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR77","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1210\/jc.2002-021171","volume":"88","author":"YK van Pareren","year":"2003","unstructured":"van Pareren YK, de Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ et al (2003) Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metabol 88:1119\u20131125","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR78","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1067\/S0022-3476(03)00246-4","volume":"143","author":"TA Wilson","year":"2003","unstructured":"Wilson TA, Rose SR, Cohen P, Rogol AD, Backeljauw P, Brown R et al (2003) Update of guidelines for the use of growth hormone in children: the Lawson Wilkins pediatric endocrinology society drug and therapeutics committee. J Pediatr 143:415\u2013421","journal-title":"J Pediatr"},{"key":"337_CR79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jpeds.2004.08.055","volume":"146","author":"JM Wit","year":"2005","unstructured":"Wit JM, Rekers-Mombarg L, Cutler GB, Crowe B, Beck TJ, Roberts K et al (2005) Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. J Pediatr 146:45\u201353","journal-title":"J Pediatr"},{"key":"337_CR80","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12020-019-01950-9","volume":"65","author":"Y Yang","year":"2019","unstructured":"Yang Y, Bai X, Yuan X, Zhang Y, Chen S, Yang H et al (2019) Efficacy and safety of long-acting growth hormone in children with short stature: a systematic review and meta-analysis. Endocrine 65:25\u201334","journal-title":"Endocrine"},{"key":"337_CR81","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1210\/jc.2013-1437","volume":"98","author":"KC Yuen","year":"2013","unstructured":"Yuen KC, Conway GS, Popovic V, Merriam GR, Bailey T, Hamrahian AH et al (2013) A long-acting human growth hormone with delayed clearance (VRS-317): results of a double-blind, placebo-controlled, single ascending dose study in growth hormone\u2013deficient adults. J Clin Endocrinol Metabol 98:2595\u20132603","journal-title":"J Clin Endocrinol Metabol"},{"key":"337_CR82","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1210\/jc.2016-3547","volume":"102","author":"N Zelinska","year":"2017","unstructured":"Zelinska N, Iotova V, Skorodok J, Malievsky O, Peterkova V, Samsonova L et al (2017) Long-acting C-terminal peptide\u2013modified hGH (MOD-4023): results of a safety and dose-finding study in GHD children. J Clin Endocrinol Metabol 102:1578\u20131587","journal-title":"J Clin Endocrinol Metabol"}],"container-title":["Handbook of Experimental Pharmacology","Pediatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2019_337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:07:37Z","timestamp":1665446857000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2019_337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030504939","9783030504946"],"references-count":83,"URL":"https:\/\/doi.org\/10.1007\/164_2019_337","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"14 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}